Altre lingue PharmaCyte Biotech, Inc.

Azioni

PMCB

US71715X2036

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 24/06/2024			Variaz. 5gg	Var. 1 gen.
2,08 ^USD	+6,67%		-5,88%	-3,70%

18/03	PharmaCyte Biotech, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 gennaio 2024	CI
2023	PharmaCyte Biotech, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 ottobre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	23/05
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease	21/05
MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc.	20/05
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	18/03
PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	18/03
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	15/12
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	15/12
Femasys Inc. announced that it has received $6.85 million in funding from PharmaCyte Biotech, Inc. and other investors	22/11
Femasys Inc. announces tranche update	17/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.	16/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	15/11
Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc.	14/11
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K	10/11
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31/10/23
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31/10/23
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology	31/10/23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	18/09/23
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	18/09/23
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K	07/09/23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	31/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue PharmaCyte Biotech, Inc.

Azioni

PMCB

US71715X2036

Altre lingue

Filtri